Streetbeat News

Price Targets

CRD

Barrington Research analyst Kevin Steinke has reiterated an 'Outperform' rating for Crawford (NYSE:CRD) with a maintained price target of $12.

Portfolio Pulse from Benzinga Newsdesk

October 11, 2024 | 6:07 pm

ARES

RBC Capital analyst Kenneth Lee has maintained an Outperform rating on Ares Management and raised the price target from $150 to $170.

Portfolio Pulse from Benzinga Newsdesk

October 11, 2024 | 6:05 pm

LRN

Barrington Research has reiterated its 'Outperform' rating for Stride (NYSE:LRN) with a maintained price target of $90, indicating confidence in the company's future performance.

Portfolio Pulse from Benzinga Newsdesk

October 11, 2024 | 6:05 pm

OKTA

Wealthy investors are showing interest in Okta (NASDAQ:OKTA) with a mix of bullish and bearish options trades. The majority of trades are calls, indicating a bullish sentiment. The targeted price range is $70 to $82.5. Okta's stock is currently priced at $78.25, with a slight increase of 0.41%.

Portfolio Pulse from Benzinga Insights

October 11, 2024 | 6:04 pm

BSIG

RBC Capital analyst Kenneth Lee maintains an Outperform rating on BrightSphere Investment (NYSE:BSIG) and raises the price target from $26 to $28.

Portfolio Pulse from Benzinga Newsdesk

October 11, 2024 | 6:03 pm

FHI

RBC Capital analyst Kenneth Lee maintains a Sector Perform rating on Federated Hermes (NYSE:FHI) and raises the price target from $35 to $36.

Portfolio Pulse from Benzinga Newsdesk

October 11, 2024 | 6:01 pm

SYM

BWS Financial analyst Hamed Khorsand has reiterated a Sell rating on Symbotic (NASDAQ:SYM) and maintained a price target of $10.

Portfolio Pulse from Benzinga Newsdesk

October 11, 2024 | 6:01 pm

IFF

Intl Flavors & Fragrances (NYSE:IFF) has been analyzed by 9 analysts, showing a range of opinions from bullish to bearish. The average 12-month price target has increased by 6.01% to $109.78. Recent analyst actions include several rating upgrades and price target increases, indicating a positive sentiment shift. However, the company faces challenges with declining revenue growth, low net margin, ROE, and ROA compared to industry averages.

Portfolio Pulse from Benzinga Insights

October 11, 2024 | 6:00 pm

CDLX

Cardlytics (NASDAQ:CDLX) has been analyzed by five analysts, showing a range of opinions from somewhat bullish to somewhat bearish. The average 12-month price target is $4.9, a significant decline from previous targets. Analysts have adjusted their ratings and price targets, reflecting challenges in Cardlytics' financial performance, including negative revenue growth and below-average profitability metrics.

Portfolio Pulse from Benzinga Insights

October 11, 2024 | 6:00 pm

MDB

In the past three months, 17 analysts have shared their evaluations of MongoDB (NASDAQ:MDB), with a mix of bullish and somewhat bullish ratings. The average 12-month price target has increased by 9.96% to $335.88. Analysts have raised their price targets, reflecting positive sentiment towards MongoDB's market position despite challenges in profitability and growth compared to industry averages.

Portfolio Pulse from Benzinga Insights

October 11, 2024 | 6:00 pm